Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
Mesa Laboratories (NASDAQ:MLAB) will release its second-quarter fiscal 2027 financial results after market close on November 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Mesa Laboratories (NASDAQ:MLAB) will release its second-quarter fiscal 2027 financial results after market close on November 9, 2026. The quarter ended September 30, 2026. An earnings conference call will follow at 4:30 p.m. Eastern Time that day, concluding with an analyst question-and-answer session. A replay will remain available for 45 days through the investor section of the company's website.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its second fiscal quarter (“2Q27”) ended September 30, 2026 following market close on Monday, November 9, 2026. The Company will also hold its earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
Details for the conference call can be found below:
| Date: | Monday, November 9, 2026 |
| Time: | 4:30 p.m. Eastern Time |
| Toll Free: | 1-833-461-5787 |
| International: | 1-585-542-9983 |
| Conference ID: | 725 558 996 |
| Webcast: | https://events.q4inc.com/attendee/725558996 |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 45 days via the investors section of the Mesa Labs website at https://investors.mesalabs.com/.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of critical quality control solutions and life sciences tools for regulated applications in the pharmaceutical, healthcare and medical device industries. With manufacturing operations in the United States and Europe, and commercial reach across North America, Europe, the Asia Pacific Region, and throughout the world, we serve customers whose applications demand accuracy, reliability and regulatory compliance.
For more information about Mesa, please visit its website at www.mesalabs.com.
Mesa Laboratories Contact:
John Sakys; CFO
1-303-987-8000
investorrelations@mesalabs.com
